-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$22.50145.37% Upside
Astria Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Astria Therapeutics, Inc.?
Astria Therapeutics, Inc. has been rated by research analysts at Oppenheimer, H.C. Wainwright in the past 90 days.